In tumor immunology, DCs are often activated by “danger signals” such as Damage-Associated Molecular Patterns (DAMPs), including ATP, HMGB1, Calreticulin (CRT), and the S100 protein family (27). The gene discussed is CALR; the disease is neoplasm.